(Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, and ...
Keaton has since reprised his role as the caped crusader on the silver screen as a major supporting character in The Flash ...
The National Comprehensive Cancer Network� (NCCN�)�an alliance of leading cancer centers�celebrated 30 years of helping peop ...
The posters will feature: 1) Clinical results for EMB-01, an EGFR x cMet bispecific antibody, in colorectal cancer; 2) Preclinical data for EM1031, a novel KLK2 x CD3 bispecific T-cell engager; 3) ...
Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...
Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials ...
Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...
BioAtla is extending its runway beyond key clinical readouts in 1H 2026 by restructuring and realigning resources, which ...
Oral and poster presentations of its DZD8586 study results in chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL) are selected by ASCO Scientific Program Committee. In ...
I’m not exactly the poster child for kindness or generosity. Many people who know me well might say that I’m kind, but others would dispute that.
Intelligencer on MSN5d
The Confessions of Insurance ExecutivesThey call him an opportunist and a vulture who’s capitalizing on a tragedy to promote his dangerous Medicare for All agenda.
Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback